Atlas Trials

Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer

Clinical trial NCT02354131 · COMPLETED

Trial details

NCT number
NCT02354131
Sponsor
Nordic Society of Gynaecological Oncology - Clinical Trials Unit
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2015-02-15
Primary completion
2018-11-15
Enrollment
108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.